Normalizing the gene-dose of Dyrk1a to two-copies in the Ts65Dn mouse model reduced levels of FL-APP and Aβ in the hippocampus and cortex (García-Cerro et al., 2017), showing that this kinase may contribute to the development of AD-pathology in DS. The gene discussed is APP; the disease is Alzheimer disease.